LEGN
Legend Biotech Corp
NASDAQ: LEGN · HEALTHCARE · BIOTECHNOLOGY
$28.12
-1.58% today
Updated 2026-05-08
Market cap
$5.28B
P/E ratio
—
P/S ratio
5.14x
EPS (TTM)
$-1.62
Dividend yield
—
52W range
$16 – $45
Volume
2.0M
WallStSmart proprietary scores
33
out of 100
Grade: F
Strong Sell
Investment rating
8.0
Growth
A5.5
Quality
C+2.0
Profitability
F6.0
Valuation
B2/9
Piotroski F-Score
Weak
0.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →195 stocks currently score above 75
Price targets
Analyst target
$57.23
+103.52%
12-Month target
—
—
Intrinsic (DCF)
$23.87
Margin of safety
+22.33%
5 Strong Buy9 Buy2 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Revenue growth 64.20% QoQ
+ 22.33% below intrinsic value
+ Debt/equity 0.41x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Altman Z 0.67 — distress zone
- Thin margins at -28.80%
- Negative free cash flow $-126.56M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $117.00M | $285.14M | $627.24M | $1.03B | $1.03B |
| Net income | $-446.35M | $-518.25M | $-177.03M | $-297.58M | $-31.03M |
| EPS | — | — | — | — | $-1.62 |
| Free cash flow | $-223.56M | $-416.00M | $-158.14M | $-168.04M | $-126.56M |
| Profit margin | -381.48% | -181.75% | -28.22% | -28.85% | -28.80% |
Peer comparison
Smart narrative
Legend Biotech Corp trades at $28.12. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 0.67, it sits in the distress. TTM revenue stands at $1.03B. with profit margins at -28.80%. Our DCF model estimates intrinsic value at $23.87.
Frequently asked questions
What is Legend Biotech Corp's stock price?
Legend Biotech Corp (LEGN) trades at $28.12.
Is Legend Biotech Corp overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell). DCF value $23.87.
What is the price target of Legend Biotech Corp (LEGN)?
The analyst target price is $57.23, representing +103.5% upside from the current price of $28.12.
What is the intrinsic value of Legend Biotech Corp (LEGN)?
Based on our DCF model, intrinsic value is $23.87, a +22.3% margin of safety versus $28.12.
What is Legend Biotech Corp's revenue?
TTM revenue is $1.03B.
Piotroski F-Score?
2/9 — weak financial health.
Altman Z-Score?
0.67 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio5.14x
ROE-29.10%
Beta0.30
50D MA$20.42
200D MA$26.77
Shares out0.18B
Float0.16B
Short ratio—
Avg volume2.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—